MET and breast cancer: The artificial heterodimerization of c-Met-FKBP and β1-FRB by the rapamycin-derived drug AP21967 promoted breast cancer cell extravasation out of circulation as shown through a tail vein metastasis assay (Jahangiri et al., 2017).